292 related articles for article (PubMed ID: 23664118)
1. Defective initiation of glycosaminoglycan synthesis due to B3GALT6 mutations causes a pleiotropic Ehlers-Danlos-syndrome-like connective tissue disorder.
Malfait F; Kariminejad A; Van Damme T; Gauche C; Syx D; Merhi-Soussi F; Gulberti S; Symoens S; Vanhauwaert S; Willaert A; Bozorgmehr B; Kariminejad MH; Ebrahimiadib N; Hausser I; Huysseune A; Fournel-Gigleux S; De Paepe A
Am J Hum Genet; 2013 Jun; 92(6):935-45. PubMed ID: 23664118
[TBL] [Abstract][Full Text] [Related]
2. Mutations in B3GALT6, which encodes a glycosaminoglycan linker region enzyme, cause a spectrum of skeletal and connective tissue disorders.
Nakajima M; Mizumoto S; Miyake N; Kogawa R; Iida A; Ito H; Kitoh H; Hirayama A; Mitsubuchi H; Miyazaki O; Kosaki R; Horikawa R; Lai A; Mendoza-Londono R; Dupuis L; Chitayat D; Howard A; Leal GF; Cavalcanti D; Tsurusaki Y; Saitsu H; Watanabe S; Lausch E; Unger S; Bonafé L; Ohashi H; Superti-Furga A; Matsumoto N; Sugahara K; Nishimura G; Ikegawa S
Am J Hum Genet; 2013 Jun; 92(6):927-34. PubMed ID: 23664117
[TBL] [Abstract][Full Text] [Related]
3. Biallelic B3GALT6 mutations cause spondylodysplastic Ehlers-Danlos syndrome.
Van Damme T; Pang X; Guillemyn B; Gulberti S; Syx D; De Rycke R; Kaye O; de Die-Smulders CEM; Pfundt R; Kariminejad A; Nampoothiri S; Pierquin G; Bulk S; Larson AA; Chatfield KC; Simon M; Legrand A; Gerard M; Symoens S; Fournel-Gigleux S; Malfait F
Hum Mol Genet; 2018 Oct; 27(20):3475-3487. PubMed ID: 29931299
[TBL] [Abstract][Full Text] [Related]
4. A B3GALT6 variant in patient originally described as Al-Gazali syndrome and implicating the endoplasmic reticulum quality control in the mechanism of some β3GalT6-pathy mutations.
Ben-Mahmoud A; Ben-Salem S; Al-Sorkhy M; John A; Ali BR; Al-Gazali L
Clin Genet; 2018 Jun; 93(6):1148-1158. PubMed ID: 29443383
[TBL] [Abstract][Full Text] [Related]
5. Insights in the etiopathology of galactosyltransferase II (GalT-II) deficiency from transcriptome-wide expression profiling of skin fibroblasts of two sisters with compound heterozygosity for two novel
Ritelli M; Chiarelli N; Zoppi N; Dordoni C; Quinzani S; Traversa M; Venturini M; Calzavara-Pinton P; Colombi M
Mol Genet Metab Rep; 2015 Mar; 2():1-15. PubMed ID: 28649518
[TBL] [Abstract][Full Text] [Related]
6. Genetic heterogeneity and clinical variability in musculocontractural Ehlers-Danlos syndrome caused by impaired dermatan sulfate biosynthesis.
Syx D; Van Damme T; Symoens S; Maiburg MC; van de Laar I; Morton J; Suri M; Del Campo M; Hausser I; Hermanns-Lê T; De Paepe A; Malfait F
Hum Mutat; 2015 May; 36(5):535-47. PubMed ID: 25703627
[TBL] [Abstract][Full Text] [Related]
7. Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers-Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (beta4GalT-7).
Seidler DG; Faiyaz-Ul-Haque M; Hansen U; Yip GW; Zaidi SH; Teebi AS; Kiesel L; Götte M
J Mol Med (Berl); 2006 Jul; 84(7):583-94. PubMed ID: 16583246
[TBL] [Abstract][Full Text] [Related]
8. Broadening the phenotypic spectrum of Beta3GalT6-associated phenotypes.
Leoni C; Tedesco M; Radio FC; Chillemi G; Leone A; Bruselles A; Ciolfi A; Stellacci E; Pantaleoni F; Butera G; Rigante D; Onesimo R; Tartaglia M; Zampino G
Am J Med Genet A; 2021 Oct; 185(10):3153-3160. PubMed ID: 34159694
[TBL] [Abstract][Full Text] [Related]
9. Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome.
Miyake N; Kosho T; Mizumoto S; Furuichi T; Hatamochi A; Nagashima Y; Arai E; Takahashi K; Kawamura R; Wakui K; Takahashi J; Kato H; Yasui H; Ishida T; Ohashi H; Nishimura G; Shiina M; Saitsu H; Tsurusaki Y; Doi H; Fukushima Y; Ikegawa S; Yamada S; Sugahara K; Matsumoto N
Hum Mutat; 2010 Aug; 31(8):966-74. PubMed ID: 20533528
[TBL] [Abstract][Full Text] [Related]
10. Ehlers Danlos Syndrome with Glycosaminoglycan Abnormalities.
Miyake N; Kosho T; Matsumoto N
Adv Exp Med Biol; 2021; 1348():235-249. PubMed ID: 34807422
[TBL] [Abstract][Full Text] [Related]
11. Ehlers-Danlos syndrome associated with glycosaminoglycan abnormalities.
Miyake N; Kosho T; Matsumoto N
Adv Exp Med Biol; 2014; 802():145-59. PubMed ID: 24443026
[TBL] [Abstract][Full Text] [Related]
12. Structural alteration of glycosaminoglycan side chains and spatial disorganization of collagen networks in the skin of patients with mcEDS-CHST14.
Hirose T; Takahashi N; Tangkawattana P; Minaguchi J; Mizumoto S; Yamada S; Miyake N; Hayashi S; Hatamochi A; Nakayama J; Yamaguchi T; Hashimoto A; Nomura Y; Takehana K; Kosho T; Watanabe T
Biochim Biophys Acta Gen Subj; 2019 Mar; 1863(3):623-631. PubMed ID: 30553867
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in the Pathophysiology of Musculocontractural Ehlers-Danlos Syndrome.
Kosho T; Mizumoto S; Watanabe T; Yoshizawa T; Miyake N; Yamada S
Genes (Basel); 2019 Dec; 11(1):. PubMed ID: 31905796
[TBL] [Abstract][Full Text] [Related]
14. Severe Peripheral Joint Laxity is a Distinctive Clinical Feature of Spondylodysplastic-Ehlers-Danlos Syndrome (EDS)-
Caraffi SG; Maini I; Ivanovski I; Pollazzon M; Giangiobbe S; Valli M; Rossi A; Sassi S; Faccioli S; Rocco MD; Magnani C; Campos-Xavier B; Unger S; Superti-Furga A; Garavelli L
Genes (Basel); 2019 Oct; 10(10):. PubMed ID: 31614862
[TBL] [Abstract][Full Text] [Related]
15. Defective glycosaminoglycan substitution of decorin in a patient with progeroid syndrome is a direct consequence of two point mutations in the galactosyltransferase I (beta4GalT-7) gene.
Götte M; Kresse H
Biochem Genet; 2005 Feb; 43(1-2):65-77. PubMed ID: 15859521
[TBL] [Abstract][Full Text] [Related]
16. A novel missense mutation in the galactosyltransferase-I (B4GALT7) gene in a family exhibiting facioskeletal anomalies and Ehlers-Danlos syndrome resembling the progeroid type.
Faiyaz-Ul-Haque M; Zaidi SH; Al-Ali M; Al-Mureikhi MS; Kennedy S; Al-Thani G; Tsui LC; Teebi AS
Am J Med Genet A; 2004 Jul; 128A(1):39-45. PubMed ID: 15211654
[TBL] [Abstract][Full Text] [Related]
17. Changes in heparan sulfate are associated with delayed wound repair, altered cell migration, adhesion and contractility in the galactosyltransferase I (beta4GalT-7) deficient form of Ehlers-Danlos syndrome.
Götte M; Spillmann D; Yip GW; Versteeg E; Echtermeyer FG; van Kuppevelt TH; Kiesel L
Hum Mol Genet; 2008 Apr; 17(7):996-1009. PubMed ID: 18158310
[TBL] [Abstract][Full Text] [Related]
18. Further defining the phenotypic spectrum of B4GALT7 mutations.
Salter CG; Davies JH; Moon RJ; Fairhurst J; Bunyan D; ; Foulds N
Am J Med Genet A; 2016 Jun; 170(6):1556-63. PubMed ID: 26940150
[TBL] [Abstract][Full Text] [Related]
19. Deficiency of the decorin core protein in the variant form of Ehlers-Danlos syndrome with chronic skin ulcer.
Wu J; Utani A; Endo H; Shinkai H
J Dermatol Sci; 2001 Oct; 27(2):95-103. PubMed ID: 11532373
[TBL] [Abstract][Full Text] [Related]
20. Alterations in glycosaminoglycan biosynthesis associated with the Ehlers-Danlos syndromes.
Syx D; Delbaere S; Bui C; De Clercq A; Larson G; Mizumoto S; Kosho T; Fournel-Gigleux S; Malfait F
Am J Physiol Cell Physiol; 2022 Dec; 323(6):C1843-C1859. PubMed ID: 35993517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
